In honor of World Rare Disease Day, Nebula Genomics has generously donated five clinical-grade whole genome sequencing tests to the Global Genes community. This test will provide patients with valuable insights to help them make informed decisions about their health.
Included in the test is the analysis of 220+ disease and 40+ carrier conditions, pharmacogenomics, and an ancestry report. Learn More
Patients will also receive the entirety of their raw genomic data in a BAM/VCF file, as well as a 30-minute virtual genetic counseling follow-up appointment to discuss their results.
In order to be considered for a sequencing test, you must live in the United States. The application period begins on February 28th and ends March 29th at 11:59pm PT. Recipients will be randomly selected and notified on Monday, April 1, 2019.
* Unfortunately, we are unable to accept applicants living in the state of New York at this time.
Patients will receive a report with details about more well-known genetic variants. This is not a diagnostic test in nature for those with complex undiagnosed disease. We will not be able to interpret any variants of unknown significance. However, patients will receive a file with their whole genome which can be interpreted by their treating geneticist or university lab. The health information is provided for general information purposes only and is not a substitute for professional health advice. Global Genes does not provide any kind of health advice. We encourage you to consult with the appropriate medical and healthcare professionals.